Spinal TRPC3 promotes neuropathic pain and coordinates phospholipase C–induced mechanical hypersensitivity
Abstract
Neuropathic pain is a debilitating chronic condition mainly caused by peripheral nerve injury. However, the cellular and molecular mechanisms underlying this condition remain unclear. Transient receptor potential canonical 3 (TRPC3), a TRP channel that is activated by downstream of the Gq-phospholipase C (PLC) axis, is expressed in the somatosensory system. Therefore, the present study investigated its pathophysiological role in neuropathic pain following peripheral nerve injury. Here, partial sciatic nerve ligation (pSNL) elicited mechanical and thermal hypersensitivity in wild-type mice, which was suppressed in TRPC3-KO mice. In situ hybridization revealed that TRPC3 is predominantly expressed in neurons in the spinal dorsal horn. Furthermore, spinal dorsal horn neuron-specific downregulation using miRNA attenuated pSNL-induced mechanical hypersensitivity. Spinal TRPC3 activation elicited acute mechanical hypersensitivity. Moreover, its genetic ablation reduced the mechanical hypersensitivity caused by spinal NK 1 R or PLC activation. These findings demonstrate that TRPC3 in spinal dorsal horn neurons facilitates the development of neuropathic pain. Therefore, TRPC3 may be a promising therapeutic target for neuropathic pain caused by peripheral nerve injury.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (10)
Shota Tobori
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Kosei Tamada
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Nagi Uemura
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Kyoko Sawada
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Masashi Kakae
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Kazuki Nagayasu
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Takayuki Nakagawa
Department of Clinical Pharmacology and Pharmacotherapy, School of Pharmaceutical Sciences, Wakayama Medical University
Yasuo Mori
Shuji Kaneko
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Hisashi Shirakawa
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University